1-4 of 4
Fan Xia
Close
Sort by
Journal Articles

Addition of Chidamide to a Sandwich Protocol, Pegaspargase, Gemcitabine and Oxaliplatin Chemotherapy Combined with Radiotherapy, As First-Line Treatment in Early Stage NK/T-Cell Lymphoma: Real World Outcomes in a Retrospective Study

Fan Xia, Nana Ping, Qi Bao, Rui Zou, Qian Zhu, Xiao Zhang, Depei Wu, Zhengming Jin, Changju Qu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6202.
https://doi.org/10.1182/blood-2023-177828
Published: 2023
Journal Articles

Zr Study: A Prospective Phase II Study of Zanubrutinib-Rituximab Chemo-Free Therapy with or without Autologous Stem Cell Transplantation in Newly Diagnosed Mantle Cell Lymphoma

Changju Qu, Nana Ping, Rui Zou, Jiajie He, Qian Zhu, Xiao Zhang, Fan Xia, Danqing Kong, Depei Wu, Zhengming Jin
Journal: Blood
Blood (2023) 142 (Supplement 1): 1658.
https://doi.org/10.1182/blood-2023-179599
Published: 2023
Journal Articles

Dual Epigenetic Agents Plus Rituximab-Gemcitabine-Oxaliplatin As a Salvage Treatment in Relapsed/Refractory Diffuse Large B Cell Lymphoma Patients

Changju Qu, PhD, Nana Ping, MD, PhD, Danqing Kong, MD, Fan Xia, MD, Depei Wu, MD PhD, Zhengming Jin, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5338.
https://doi.org/10.1182/blood-2019-128111
Published: 2019
Journal Articles

Radiotherapy Priming Chimeric Antigen Receptor T Cell Therapy Is a Safe and Promising Approach in Relapsed/Refractory Diffuse Large B Cell Lymphoma Patients with High Tumor Burden

Changju Qu, MD, PhD, Nana Ping, MD, PhD, Qian Wu, MD, Liqing Kang, Fan Xia, MD, Lei Yu, Depei Wu, Zhengming Jin
Journal: Blood
Blood (2018) 132 (Supplement 1): 2961.
https://doi.org/10.1182/blood-2018-99-113979
Published: 2018